Jharkhand: Three-Month-Old Child Dies After Vaccination

Ramgarh (PTI) A three-month-old child has died 24 hours after he was administered a vaccine at a community health centre in Jharkhand’s Ramgarh district, a health official said on Friday.

Ramgarh Civil Surgeon Dr Prabhat Kumar said a medical board has been formed to ascertain the cause of the death.

Viscera will be preserved for a detailed enquiry of the case, Kumar said, adding that a state team of the World Health Organisation (WHO) will probe the rare case of a child’s death after vaccination.

The child, Abhiraj Kumar, was administered the pentavalent vaccine, which protects children from deadly diseases such as Diphtheria, Pertussis, Tetanus and Hepatitis-B, by paramedical staffers at the CHC at Patratu on Thursday and his condition deteriorated, a police officer said.

The child was taken to a hospital, where he died early on Friday, he said.

His parents, Bablu Sao and Lalita Devi, however, alleged that their son died due to negligence and unsafe vaccination and demanded that those responsible be arrested and booked under murder charges.

  • Related Posts

    • Pharma
    • July 10, 2025
    • 109 views
    Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

    India stands tall as a pharmaceutical powerhouse, supplying 20% of the world’s generic medicines and nearly 62% of global vaccines. Yet, this success now faces a storm: US President Donald…

    • Pharma
    • July 10, 2025
    • 98 views
    Novartis wins approval for first malaria drug for newborns and babies

    ZURICH: Novartis (NOVN.S), opens new tab said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat malaria in babies…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

    Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

    Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

    Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

    Novartis wins approval for first malaria drug for newborns and babies

    Novartis wins approval for first malaria drug for newborns and babies

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr